ITEA 4 page header azure circular

Context-aware Yaro conversational reflection capability

Project
22022 TREAT
Type
Enhancement
Description

Yaro is a conversational health-reflection capability integrated with My Viva Plan. It supports guided, personalized conversations relating to nutrition, physical activity, mental well-being, lifestyle goals and daily experiences. Through TREAT, Yaro was enhanced to operate within an interoperable workflow that can combine user-profile data, patient-reported information, lifestyle journals, available wearable data, approved clinical context and AI recommender outputs.

Unlike a generic chatbot, Yaro is designed for structured wellness reflection and longitudinal engagement. It applies health-safety controls intended to prevent diagnosis, medical advice and unsupported interpretation of clinical measurements. Its outputs can be structured for use within My Viva Plan and for controlled exchange with connected clinical platforms.

The result can be reused as a patient-engagement component within digital-health, chronic-disease-management and remote-monitoring programs, subject to appropriate privacy, security, clinical-governance and implementation controls.

Contact
Nathanial Maeda
Email
nathanial.maeda@myvivaplan.com
Research area(s)
Digital health; conversational artificial intelligence; lifestyle medicine; patient self-management; health-data interoperability; human-centred AI
Technical features

Conversational interface embedded within My Viva Plan. Guided reflection across nutrition, physical activity, mental well-being and lifestyle goals. Contextualization using authorized profile, goal, journaling and reflection information. Ability to incorporate available wearable, device and approved EMR-derived context. Integration with external recommender outputs to inform conversation topics. Structured conversation summaries and reflections that may be returned to connected platforms. Standards-based exchange within the TREAT-Complete architecture, including HL7 FHIR-formatted information and RabbitMQ-based messaging. Azure-hosted AI components, including Azure OpenAI and Azure AI Search. Feature-controlled access for study or defined user groups. Data-minimization, de-identification, secure storage and audit-oriented controls. Safety guardrails that redirect medical, diagnostic and crisis-related matters to qualified human services.

Integration constraints

Requires an authorized My Viva Plan environment and user identity. Production use requires configured access to the relevant My Viva services, databases and APIs. External clinical or device integrations require agreed data mappings, patient-identity linkage and secure transfer mechanisms. TREAT-Complete integration uses standardized FHIR resources and configured RabbitMQ messaging routes. Yaro does not directly process all raw FHIR resources; relevant information may need to be normalized into a simplified, My Viva-compatible structure before conversational use. Deployment involving identifiable health information requires privacy, security, consent, retention and access controls appropriate to the applicable jurisdiction. Clinical implementations require governance that clearly limits Yaro’s role and prevents use as a diagnostic, emergency or medical-advice service. Azure OpenAI, Azure AI Search and related cloud services require appropriate contractual, data-residency and security configuration

Targeted customer(s)

Healthcare organizations, primary-care networks, chronic-disease programs, digital-health providers, remote-patient-monitoring programs, health insurers and payers, research organizations, and technology partners seeking a patient-facing conversational capability. Potential clinical applications include type 2 diabetes, obesity, cardiometabolic health and other conditions where sustained lifestyle self-management and engagement are important.

Conditions for reuse

Reuse is subject to a commercial licence or written agreement with My Viva Inc.

Confidentiality
Public
Publication date
10-11-2026
Involved partners
My Viva Inc. (CAN)